340B, Biosimilars, Congress, FDA, HHS, hospitals, insurance, life sciences, Medicare Part B, Medicare Part D, pharmaceuticals, pharmacy, pharmacy benefit manager Ron Lanton 340B, Biosimilars, Congress, FDA, HHS, hospitals, insurance, life sciences, Medicare Part B, Medicare Part D, pharmaceuticals, pharmacy, pharmacy benefit manager Ron Lanton

Lanton Law Speaks at Summit & Reverse Expo

We were pleased to be invited to Orlando, Florida to speak with IDN with our presentation titled “Price, Innovation & Policy: What’s on the Horizon for the Industry.

We were pleased to be invited to Orlando, Florida to speak with IDN with our presentation titled “Price, Innovation & Policy: What’s on the Horizon for the Industry.

Read More